Published on 9 May 2024 on Investor's Business Daily
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Leerink Partners analyst Marc Goodman says crinecerfont could eventually reach $900 million in sales...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free